Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Social Media Discussions Provide new Insight About Perceptions of Hydroxyurea in the Sickle Cell Community
source: American Journal of Hematology
year: 2019
authors: Walker AL, Gaydos LM, Farzan R, De Castro L, Jonassaint C
summary/abstract:Hydroxyurea (HU) has proven efficacious for treating sickle cell disease (SCD) and is recommended for most patients. However, HU is underutilized and reasons for lack of uptake are unclear. Past qualitative studies to identify barriers have been small and limited to clinical settings. Thus, to better understand barriers to HU there is a need to explore perceptions of patients and families from the broader community. We conducted a qualitative study of Facebook messages posted in an online sickle cell support group to identify barriers and facilitators to hydroxyurea use.
We collected a total of 22 223 user‐generated original messages and comments posted in the SCD Unite group between January 2014 and November 2015. From these messages, we identified those containing any of the following terms: “Hydrea,” “Droxia,” “Hydroxycarbamide,” “Hydroxurea,” “Hydroxy,” “HU,” “Urea,” and “hydro*,” along with the comments associated with these posts. All nontext based posts (ie, pictures, videos, and links) were excluded.
The resultant data set included 145 total original messages and 2618 associated comments. We performed content coding and analysis on all 145 original message posts followed by thematic analysis of a select subset of discussion threads, which were defined as a single original message plus their associated comments.
organization: University of Pittsburgh, USA; Emory University, USADOI: 10.1002/ajh.25430
read more full text
+myBinderRelated Content
-
The Hazards of Hazardous Drug Labeling: Time to Revisit Hydroxyurea?Despite benefits in reducing pain crises...
-
Building Capacity to Reduce Stroke in Children With Sickle Cell Anemia in the Dominican Republic: The SACRED TrialThe prevalence of sickle cell anemia (SC...
-
GBT and SCDAA Kick Off “Lift Every Voice to Shine the Light on Sickle Cell”In recognition of World Sickle Cell Day,...
-
Coronavirus Preparedness for People With Chronic Diseaseshttps://www.youtube.com/watch?v=G_JC3vUT...
-
Sickle cell adult and pediatric provider interview – Dr Nirmish Shahhttps://www.youtube.com/watch?v=6fFmmPrd...
-
Increasing Appointment Attendance: A Vital Opportunity to Improve Health Outcomes for Those Living with Sickle Cell ...Sickle cell disease (SCD) affects approx...
-
Developing Hydroxyurea, the First FDA-Approved Therapy for Sickle Cell Diseasehttps://www.youtube.com/watch?v=0kIz5ZKy...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.